Search Results

Site Search

New Tests Launched in February - Insights

In February 2017, Mayo Medical Laboratories announced nine brand new tests along with numerous reference-value changes, obsolete tests, and algorithm changes.

William Morice II, M.D., Ph.D., considers the future of diagnostics - Insights

Dr. Morice talks about what lies ahead for laboratory medicine and how the opportunities and challenges in the field are intertwined.

Informatics for the Pathologist - Insights

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Justin Juskewitch, M.D., Ph.D., and Andrew Norgan, M.D., Ph.D., both assistant professors of laboratory medicine and pathology at Mayo Clinic, to talk about...

Mayo Clinic receives first-of-its-kind accreditation for diagnosis of primary ciliary dyskinesia - Insights

Mayo Clinic is the first and only PCD Foundation accredited center for the diagnosis of primary ciliary dyskinesia, a rare and debilitating lung disease.

Updated authentication for Mayo Clinic Laboratories - Insights

On Saturday, March 13 at 6 p.m. CT, Mayo Clinic Laboratories will be migrating to the authentication service used across Mayo Clinic.

Updated authentication for MayoACCESS client test environment - Insights

Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.

Web Test Catalog Changes - Insights

On Tuesday, May 11, 2021, several changes will be made to the information displayed on the Mayo Clinic Laboratories online test catalog. These changes will improve accuracy and clarity of important information regarding test performanc

April new tests - Insights

In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in March - Insights

In March 2020, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in May - Insights

In May 2020, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in December - Insights

In December 2019, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in January - Insights

In January 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in June - Insights

In June 2020, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in October - Insights

In October 2019, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in June - Insights

In June 2019, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in April - Insights

In April 2019, Mayo Clinic Laboratories announced nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New tests launched in January - Insights

In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.

Mary Jo Williamson discusses organizational alignment on Becker's Healthcare Podcast - Insights

Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, joins “Becker’s Healthcare Podcast” to discuss organizational alignment during times of change. She shares her expertise on creating transparency, fostering open...

"Mayo Clinic Q&A" highlights Mayo Clinic Laboratories' work on COVID-19 - Insights

On the podcast, Dr. William Morice described how Mayo Clinic Laboratories quickly ramped up to meet pandemic testing needs.

New Tests Launched in September - Insights

In September 2017, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Gastrointestinal Stromal Tumor Panel [Test in Focus] - Insights

Rondell P. Graham, M.B.B.S., gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, what clinical action can...

Bobbi Pritt, M.D., named IDSA Featured Educator for May - Insights

Recognizing Dr. Pritt’s innovative work in medical education, the Infectious Diseases Society of America is highlighting her role as an educator in its monthly series.

Challenges of Saliva Testing - Insights

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Darci Block, Ph.D., assistant professor of Laboratory Medicine and Pathology and consultant in Clinical Core Laboratory Services at Mayo Clinic, to discuss...

AABB Guidelines for Convalescent Plasma - Insights

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with ¬¬¬¬¬Dr. Jeffrey Winters, Chair of the Division of Transfusion Medicine, and Professor of Laboratory Medicine and Pathology at Mayo Clinic, to talk about the new...

Autoimmune Movement Disorders - Mayo Clinic Laboratories

Our phenotype specific testing for autoimmune movement disorders contain clinically relevant antibodies providing accurate answers for treatment guidance.

Neurogenetic Testing - Mayo Clinic Laboratories

We offer comprehensive neurogenetic testing, backed by a multidisciplinary team of clinical neurology experts, laboratory scientists, and genetic counselors, to provide the highest standard for mutation detection and depth of coverage.

Driving change in women's health testing through pioneering research and novel testing strategies - Insights

New diagnostic tests specifically for conditions that predominantly or only affect women, such as autoimmune diseases and gynecological cancers, are empowering female patients and their physicians to make informed decisions.

Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the...

Black History Month: Bill Morice, M.D., Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to honor Black...

Mayo Clinic Study on Plasma Ceramides Featured in Clinical Laboratory News - Insights

Clinical Laboratory News recently highlighted a Mayo Clinic study that shows how plasma ceramides may predict cardiovascular events in patients with or without coronary artery disease.

Industry Updates From the Nation's Capital: Bill Morice, M.D., Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss...

Join Mayo Clinic Laboratories at Crohn's and Colitis Congress - Insights

Mayo Clinic Laboratories, a leader in gastroenterology and patient care, will be exhibiting at the Crohn's & Colitis Congress, a premier conference for health care professionals and researchers interested in inflammatory bowel disease...

Week in Review: January 13 - Insights

Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly...

William Morice, II, M.D., Ph.D., Featured on ESPN Radio - Insights

Dr. Morice, chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology and president of Mayo Clinic Laboratories, discusses the latest COVID-19 testing and the upcoming sports season.

National symposium to feature Ana Casanegra, M.D. reviewing direct-acting anticoagulants - Insights

On Dec. 4, Mayo Clinic Laboratories will host the Friday Satellite Symposium A Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis, preceding the 62nd American Society of Hematology Annual Meeting and...

Mayo Clinic Laboratory and Pathology Research Roundup: April 30 - Insights

This week's research roundup feature: Patients with dementia with Lewy bodies (DLB) may have Alzheimers disease (AD) pathology that can be detected by plasma biomarkers. Our objective was to evaluate plasma biomarkers of AD and their...

Mayo Clinic Laboratory and Pathology Research Roundup: April 23 - Insights

This week's research roundup feature: Only 20 percent of renal and bladder cancer patients will show a significant response to immune checkpoint inhibitor (ICI) therapy, and no test currently available accurately predicts ICI response. We...

William Morice, II, M.D., Ph.D., Featured in The Athletic - Insights

Dr. Morice was recently featured in The Athletic regarding sports teams and how to safely and efficiently bring them back.

Week in Review: February 17 - Insights

Today's Highlights Include: CDC adds COVID vaccine to routine immunization schedule for kids and adults, Governments target medical debt with COVID relief funds and Minnesota being the 1st state to screen all newborns for serious viral...

Using Data-Driven, In-Person Discussions to Support Outreach Clients - Insights

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton. They...

CPT codes and LOINC update: July 2024 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of July.

Bobbi Pritt, M.D., on Asian Longhorned Tick in U.S - Insights

According to the Centers for Disease Control and Prevention (CDC), the Asian longhorned tick has spread across nine states since it first appeared in the U.S. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and...

Select Agents Module - Insights

Select Agents Module Expires: May 8, 2025 Overview This module reviews the characteristics of Select Agent organisms. Participants will read about Select

CPT codes and LOINC update: September 2024 - Insights

This page lists updates posted to Mayo Clinic Labs during the month of September.

Infectious disease test gains U.S. FDA approval - Insights

An ideal testing partner will offer extensive expertise in assay development and analytical validation services, along with access to biospecimens. In this collaboration example, learn how Mayo Clinic Laboratories’ BioPharma Diagnostics...

Oncology surveillance biomarker study enrolls patients and evaluates assay - Insights

Mayo Clinic Laboratories’ BioPharma Diagnostics team supports companies from discovery to post-market in advancing their precision medicine initiatives. In this collaboration example, learn how BioPharma Diagnostics helped a biotech company...

Gastrointestinal study collects and tests patient specimens at multiple touchpoints - Insights

Mayo Clinic Laboratories’ BioPharma Diagnostics team collaborates with biopharmaceutical, diagnostic, and other research companies to offer a wide range of laboratory testing and biopharma support for all phases of clinical trials. In this...

Neurology study validates Alzheimer's assays - Insights

Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates specimen collections and access to archived samples to support clinical trials and diagnostic validation projects that advance healthcare. In this collaboration example, learn...

Join us at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit - Insights

BioPharma Diagnostics executives will attend the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit, set to take place in Boston, Massachusetts, from April 23 –25. They will be available to meet with attendees to discuss how our...